Praxis Precision Medicines (PRAX) said late Thursday it plans a public offering of shares and prefunded warrants.
The company also said it plans to grant its underwriters, including
TD Cowen and Piper Sandler, a 30-day option to buy more shares.
Praxis shares were up over 4% during after-hours activity.